A recent investigation by researchers at Banaras Hindu University has revealed that about one in three people vaccinated with Covaxin recipients experienced significant side effects. This one-year study observed these effects in both teenagers and adults.

The research, which included 926 participants, found that half of them reported infections, mainly upper respiratory ones, after vaccination. Additionally, serious health issues like strokes and Guillain-Barre syndrome occurred in 1% of the subjects.

Covaxin recipients experienced
Source: The Indian Express

The study, published in Springer Nature, follows AstraZeneca’s admission in a UK court that its vaccine may lead to uncommon but severe complications like blood clots and reduced platelet counts.

Specific Findings

The study detailed that skin issues, general health disturbances, and neurological problems were the most frequent side effects in young people post-vaccination. For adults, general health issues, muscle and bone problems, and neurological conditions were more common.

Among female participants, 4.6% experienced menstrual irregularities. Eye problems and thyroid issues were also noted in a small percentage of the subjects. Tragically, four adults with diabetes passed away, with strokes and a rare fungal infection post-COVID-19 being the main causes of death.

Looking Forward

The researchers emphasized the need for ongoing monitoring of vaccinated individuals to better understand and manage these side effects. They also suggested that serious side effects might be more common than previously thought, highlighting the need for larger studies to investigate vaccine-related immune responses.

The study concluded that women, those with previous health conditions, and individuals who had contracted typhoid after vaccination were at a higher risk of prolonged side effects. Adults with underlying health issues were twice as likely to experience these adverse effects. Those who received either one or three doses of Covaxin faced a greater risk compared to those who had two doses.

You might also be interested in - Following AstraZeneca’s side effects, concerns arise over adverse events in some Covaxin recipients